PHILADELPHIA, PA–On February 23, a jury awarded $2.5 million in damages to a 20-year-old man with autism who took Johnson & Johnson's antisphycotic drug Risperdal as a teen and grew size 44D breasts.
"This trial is important publicly because it provided for the first time a window into the real risks of the drug," said one of the man's attorneys, Thomas R. Kline of Kline & Specter, who has been trying drug cases for 37 years.